Effect of Health Education on Promoting Influenza Vaccination Health Literacy

Sponsor
Sun Yat-sen University (Other)
Overall Status
Recruiting
CT.gov ID
NCT06048406
Collaborator
(none)
3,036
1
2
9.5
319.8

Study Details

Study Description

Brief Summary

The goal of this cluster randomized controlled trial is to evaluate the effect of health education interventions on influenza vaccination rates and health literacy in primary school students in the city of Dongguan in China.

Individuals aged 7 to 12 years who are in grades 4-5 in primary schools in Dongguan will be enrolled. 20 primary schools will be randomly selected, with half designated as intervention group schools and the remaining half as control group schools. The intervention group will receive a monthly health education intervention focused on influenza vaccination for 5 months, while the control group will continue with their routine school health education for 5 months.

Researchers will compare the differences in influenza vaccination rates and influenza vaccination health literacy levels between the intervention and control groups after 5 months to see if health education can promote influenza vaccination health literacy among primary school students.

Condition or Disease Intervention/Treatment Phase
  • Combination Product: Health education
N/A

Detailed Description

Introduction: Influenza is a major public health threat, and vaccination is the most effective prevention method. However, vaccination coverage remains suboptimal. Low health literacy regarding influenza vaccination may contribute to vaccine hesitancy. This study aims to evaluate the effect of health education interventions on influenza vaccination rates and health literacy.

Methods and analysis: This cluster randomized controlled trial will enroll 3036 students in grades 4-5 from 20 primary schools in Dongguan City, China. Schools will be randomized to an intervention group receiving influenza vaccination health education or a control group receiving routine health education. The primary outcome is influenza vaccination rate. Secondary outcomes include health literacy levels, influenza diagnosis rate, influenza-like illness incidence, and vaccine protection rate. Data will be collected through questionnaires, influenza surveillance, and self-reports at baseline and study conclusion.

Ethics and dissemination: Ethical approval has been sought from the Ethics Committee of the School of Public Health, Sun Yat-sen University. Findings from the study will be made accessible to both peer-reviewed journals and key stakeholders.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
3036 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Masking Description:
Outcomes Assessor will not know the intervention status of the participants.
Primary Purpose:
Health Services Research
Official Title:
Effect of Health Education on Promoting Influenza Vaccination Health Literacy Among Primary School Students
Actual Study Start Date :
Sep 15, 2023
Anticipated Primary Completion Date :
Jun 30, 2024
Anticipated Study Completion Date :
Jun 30, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention

The intervention group will receive a monthly health education intervention focused on influenza vaccination literacy for 5 months.

Combination Product: Health education
The intervention group will receive a health education intervention focused on influenza vaccination literacy, while the control group will continue with their standard school health education without any additional intervention. An influenza vaccination health education including topics such as the importance of influenza vaccination, benefits of vaccination, and vaccination methods, will be developed and reviewed by an expert group. The package for the intervention group will include educational activities, distribution of promotional materials, vaccination services, and distribution of vaccination souvenirs.

No Intervention: Control

The control group will continue with their routine school health education for 5 months.

Outcome Measures

Primary Outcome Measures

  1. influenza vaccination rate [Within 20 weeks from enrollment]

    he influenza vaccination rate will be calculated as the number of vaccinated individuals divided by the total number of individuals, multiplied by 100%.

  2. influenza vaccination health literacy level [baseline and 20 weeks]

    Regarding the influenza vaccination health literacy level, each correct answer for the health literacy research questionnaire will be scored as one point, with incorrect answers receiving no points. Based on the scores, health literacy levels will be categorized as low, medium, or high.

Secondary Outcome Measures

  1. influenza incidence [Within 20 weeks from enrollment]

    The influenza incidence will be calculated as the number of individuals diagnosed with influenza divided by the total number of individuals, multiplied by 100%

  2. influenza vaccine protection rate [Within 20 weeks from enrollment]

    The influenza vaccine protection rate will be calculated as the difference between the incidence rate in unvaccinated individuals and the incidence rate in vaccinated individuals, divided by the incidence rate in unvaccinated individuals, multiplied by 100%.

  3. influenza-like illness incidence [Within 20 weeks from enrollment]

    The ILI incidence will be calculated as the number of ILI cases divided by the total number of participants, multiplied by 100%.

Eligibility Criteria

Criteria

Ages Eligible for Study:
7 Years to 12 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Primary school students within the age range of 7-12 years.

  • Students and their parents who voluntarily agree to participate in the study and provide signed informed consent.

  • Permanent residents of Dongguan City who are expected to complete the project without transferring schools during the study period.

Exclusion Criteria:
  • Individuals with contraindications to influenza vaccination, who have recently received an influenza vaccination, diagnosed with influenza or confirmed as influenza-like cases at the commencement of the study.

  • Unwilling to participate in the project.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Dongguang Center for Disease Control and Prevention Dongguang Guangdong China 510000

Sponsors and Collaborators

  • Sun Yat-sen University

Investigators

  • Principal Investigator: Lin Xu, PhD, Sun Yat-sen University

Study Documents (Full-Text)

More Information

Publications

None provided.
Responsible Party:
Lin Xu, Professor, Sun Yat-sen University
ClinicalTrials.gov Identifier:
NCT06048406
Other Study ID Numbers:
  • SunYat-senU20230908
First Posted:
Sep 21, 2023
Last Update Posted:
Sep 22, 2023
Last Verified:
Sep 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Lin Xu, Professor, Sun Yat-sen University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 22, 2023